ClinicalTrials.gov: Part 3 - CDER’s Compliance and Enforcement Activities

Part three of a three-part webinar series, FDA provides an understanding of CDER’s role and responsibilities with respect to ClinicalTrials.gov oversight; including examples of compliance and enforcement activities CDER has taken to encourage compliance.

Speakers:

Rachelle Swann, Pharm.D.
Lead Pharmacologist
Division of Enforcement and Postmarketing Safety (DEPS)
Office of Scientific Investigations (OSI)
Office of Compliance (OC)
Center for Drug Evaluation and Research (CDER) | FDA


Learn more at: https://www.fda.gov/drugs/news-events...

-----------------------

FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Upcoming Training - https://www.fda.gov/cdersbia
SBIA Listserv - https://public.govdelivery.com/accoun...
SBIA 2022 Playlist -    • 2022 CDER Small Business and Industry...  
SBIA LinkedIn -   / cder-small-business-and-industry-assistance  
SBIA Training Resources - https://www.fda.gov/cdersbialearn
Twitter -   / fda_drug_info  
Email - [email protected]
Phone - (301) 796-6707 I (866) 405-5367